[serum drop]Moregate Exports

History Timeline 1975-1996


Operations begin, first foetal calf serum exported to Europe.

 

Production of foetal calf serum at 3,000 litres per annum.

First shipment of Foetal Calf Serum to the United Kingdom.

New Zealand operations commenced. New Born Calf Serum processed for first time.

Production of Foetal Calf Serum approaching 10,000 litres per annum.

Animal By Products introduced. Other Animal Sera introduced.

 

Production of Foetal Calf serum at 15,000 litres per annum.

Research commenced into specific plasma for U.K. company.

 

Production of Foetal Calf Serum at 18,000 litres per annum.

Joint Venture with MIRINZ established to research value added by-products in N.Z.

 

Production of Foetal Calf Serum at 25,000 litres per annum.

Expanding of animal by products.

 

Adding new products in Australia. Calf blood from cattle up to six months old produced to customers spec.

Commencement of DITAC supported Generic Research Program to add value to Australian animal by products.Defibrinated Adult Bovine Serum now shipped in large volumes to pharmaceutical manufacturer in Europe.First large scale BSA batch produced using process developed by Generic Research Program.BSA production successfully commercialised and customer base established.
1975  1976-19791980198219841986  198719881989199019921993199419951996
Between 1975 and 1979 operations into Europe continued to expand.

 

Total production by the end of the 1970's grew to 6,000 litres of Foetal Calf Serum.

First shipments of Foetal Calf Serum to Japan.

 

Production of Foetal Calf Serum approaching 12,500 litres per annum.

First shipments of Foetal Calf Serum to the United States.New Zealand operations expanded, full range of Bovine Sera and Plasma now produced.

 

Production of Foetal Calf Serum passes 20,000 litres per annum.

New GMP processing lab built in Australia.Commissioning of filtration plant in New Zealand. Customer audit passed.Establishment of Donor Bovine herd in New Zealand.Adult Bovine Serum shipped in large volumes to pharmaceutical manufacturer in the U.S.A.

| Home |